idiopathic thrombocytopenic purpura. Idiopathic thrombocytopenic purpura
Conditions
Interventions
Intervention 1: Intervention: people with eradication of H. pylori infection who were treated. Intervention 2: control groups: those without infection with H. pylori infection is not treated.
Treatment - Drugs
Intervention: people with eradication of H. pylori infection who were treated
control groups: those without infection with H. pylori infection is not treated
Sponsors
Arak University of Medical Sciences
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: Inclusion criteria: patients with thrombocytopenia purpura ideopatic andy with Helicobacter pylori infection and treatment. Exclusion criteria: patients with autoimmune disorders? HIV? hepatitis? drug-induced thrombocytopenia? patients who two years ago against Helicobacter pylori have received medical treatment? patients at 4 weeks of antibiotic or protein pump inhibitors have used
Exclusion criteria
Exclusion criteria:
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| PLATELET. Timepoint: monthly. Method of measurement: CBC. | — |
Secondary
| Measure | Time frame |
|---|---|
| Helicobacter pylori infection. Timepoint: monthly. Method of measurement: Helicobacter pylori antibody test. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactJebali Hossein
University of Medical Sciences arak
Outcome results
None listed